Table 4 Longitudinal assessments in follow-up early PD patients
Characteristics | Baseline (n = 39) | Follow-up (n = 39) | p value |
|---|---|---|---|
Age (years) | 68.5 ± 7.7 | / | / |
Sex, N | / | ||
Male | 26 | / | / |
Female | 13 | / | / |
Disease duration (years) | |||
UPDRS I | 3.3 ± 2.7 | 6.3 ± 4.1 | < 0.001*** |
UPDRS II | 9.9 ± 4.3 | 12.1 ± 4.8 | 0.041 |
UPDRS III | 18.8 ± 8.5 | 26.9 ± 9.6 | < 0.001*** |
NMSQ | 8.2 ± 4.1 | 10.6 ± 4.3 | 0.014 |
SS-16 | 6.7 ± 3.3 | 5.6 ± 2.5 | 0.099 |
RBDSQ | 5.0 ± 4.3 | 5.7 ± 3.6 | 0.45 |
HAMD-17 | 5.7 ± 4.4 | 6.1 ± 4.7 | 0.71 |
SCOPA-AUT | 13.8 ± 9.6 | 16.1 ± 8.5 | 0.27 |
MMSE | 27.2 ± 3.5 | 27.5 ± 2.8 | 0.60 |
MoCA | 23.2 ± 5.2 | 22.8 ± 5.4 | 0.76 |